Journal of Surgical Oncology

Papers
(The H4-Index of Journal of Surgical Oncology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Current monitoring and treatment for anal intraepithelial neoplasms76
60
JSO seminar series: Global inequities in access to cancer care and strategies to address them51
35
Issue Information32
Extent of macroscopic vascular invasion predicts distant metastasis in primary leiomyosarcoma of the inferior vena cava32
Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends31
Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma30
Delayed Esophagectomy After Chemoradiation Is Not Associated With Increased Mortality or Recurrence28
A novel mini‐retractor for retroperitoneal laparoscopic partial nephrectomy27
Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas26
Prediction of symptomatic anastomotic leak after rectal cancer surgery26
24
Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy23
Fifty years of bone tumors22
Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple‐Negative Breast Cancer Patients22
Validation of a Clinicopathologic and Gene Expression Model for Predicting Sentinel Node Metastasis in Melanoma: A Multicenter Danish Cohort Study22
Three‐dimensional technologies in chest wall resection and reconstruction22
Development and Validation of a Predictive Score for Preoperative Detection of Lymphovascular Invasion in Rectal Cancer22
Monitoring Treatment Response in Rectal Cancer through Circulating Tumor Cell Dynamics: A Pilot Clinical Study21
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non‐metastatic clear cell renal carcinoma21
0.10928392410278